GB Patent

GB201208293D0 — Hydrochlorice salt of peptide

Assigned to Niox Healthcare Ltd · Expires 2012-06-20 · 14y expired

What this patent protects

Patent listed against leuprolide-mesylate.

Drugs covered by this patent

leuprolide-mesylate (LEUPROLIDE MESYLATE)

Patent Metadata

Patent number: GB201208293D0
Jurisdiction: GB
Classification: —
Expires: 2012-06-20
Drug substance claim: No
Drug product claim: No
Assignee: Niox Healthcare Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.